Fallopian Tube Cancer

Fallopian tube cancer is a very rare gynaecological cancer that develops from the fallopian tubes in the female reproductive system. The fallopian tubes, also known as uterine tubes or oviducts, are a pair of hollow j-shaped tubes that connect the ovaries to the uterus.

The fallopian tubes are approximately 10-12 centimetres long and 1-4 millimetres in diameter. These structures have three primary functions, including the transportation of ova (also known as eggs or oocytes) from the ovaries to the uterus, the transportation of male sperm cells from the uterus to the ova, and to provide a suitable environment for the fertilisation process to take place. It is a common misconception that fertilisation occurs in the uterus, but it actually occurs in the fallopian tubes and forms a zygote (a fertilised egg). Once formed, the zygote travels from the fallopian tubes to the uterus, and implants itself into the uterine wall for the gestation (pregnancy) period.

Fallopian tube cancers are most common in women over the age of 50. However, it can affect anyone with fallopian tubes – including women, teenagers, transgender men, non-binary individuals, and intersex people – at any age.

Types of Fallopian Tube Cancer

There are three primary types of fallopian tube cancer, which are classified by the location that the cancer develops from.

Papillary Serous Adenocarcinoma

Papillary serous adenocarcinomas are the most common type of fallopian tube cancer, and develop from the mucus-producing cells that line the fallopian tubes. These tumours can be high grade or low grade, have varying levels of aggressiveness and varying metastasis rates. As such, the prognosis of this subtype often varies.

Leiomyosarcoma

Leiomyosarcoma (LMS) is a rare form of sarcoma (cancer arising from bone, connective tissue and/or soft tissue) that develops in smooth muscle cells. It is most commonly found in the abdomen or uterus; however, it can also be found in the skin, blood vessels, bones, or rarely, the fallopian tubes.
Leiomyosarcomas of the fallopian tubes are generally difficult to diagnose, highly aggressive and likely to metastasise. As such, they may not have as good of a prognosis as other types of fallopian tube cancer.

For more information on Leiomyosarcoma, please refer to the Rare Cancers Australia Leiomyosarcoma page.

Transitional Cell Carcinoma

Transitional cell carcinomas are a very rare subtype of fallopian tube cancer, and develop in the transitional cells (the cells that can change shape and stretch to allow for expansion without breaking) of the fallopian tubes. Because of how rare these cancers are, there has limited research done into the aggressiveness and prognosis of this disease.

Rare types of Fallopian Tube Cancer

These types of fallopian tube cancer are considered very rare:

  • Clear cell carcinoma.
  • Endometrioid carcinoma.
  • Adenosquamous carcinoma.
  • Squamous cell carcinoma (SCC).

Treatment

If fallopian tube cancer is detected, it will be staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you.

Fallopian tube cancers can be staged using the Federation of Gynecology and Obstetrics (FIGO) system from stage I to IV:

  • Stage I: cancer cells are confined to cervix tissue only. This stage is also known as early-stage cancer.
  • Stage II: cancer cells have spread to the upper two-thirds of the vagina and/or other nearby tissue. This is also known as localised cancer.
  • Stage III: the cancer has become larger and has spread to lower third of the vagina and/or the side of the pelvic wall. Lymph nodes and kidneys may be affected. This is also known as advanced or metastatic cancer.
  • Stage IV: the cancer has spread to the bladder or rectum, or to more distant organs, such as the lungs or the liver. This is also known as advanced or metastatic cancer.

Cancers can also be graded based on the rate of growth and how likely they are to spread:

  • Grade I: cancer cells present as slightly abnormal and are usually slow growing. This is also known as a low-grade tumour.
  • Grade II: cancer cells present as abnormal and grow faster than grade-I tumours. This is also known as an intermediate-grade tumour.
  • Grade III: cancer cells present as very abnormal and grow quickly. This is also known as a high-grade tumour.

Once your tumour has been staged and graded, your doctor may recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment is dependent on several factors, including fertility, type, stage of disease and overall health.

Treatment options for fallopian tube cancers may include:

  • Surgery, potentially including:
    • Hysterectomy.
    • Unilateral or bilateral salpingectomy.
    • Bilateral salpingo-oophorectomy.
    • Unilateral salpingo-oophorectomy.
    • Lymphadenectomy.
    • Removal of other organs (only required in some cases where the cancer has spread beyond the pelvis).
    • Omentectomy.
    • Bowel resection (advanced fallopian cancers that have metastasised to the intestines).
  • Chemotherapy.
  • Targeted therapy.
  • Hormone therapy.
  • Radiation therapy (rare).
  • Clinical trials.
  • Palliative care.

Fallopian Tube Cancer Treatment and Fertility

Treatment for fallopian tube cancer may make it difficult to become pregnant. If fertility is important to you, discuss your options with your doctor prior to the commencement of treatment.

Risk factors

While the cause of fallopian tube cancer remains unknown, the following factors may increase the likelihood of developing the disease:

  • A family history of ovarian, breast, bowel, or fallopian tube cancer.
  • Genetic mutations, especially of the BRAC1 and BRAC2 genes.
  • Having Lynch syndrome (also known as hereditary nonpolyposis colon cancer or HNPCC).
  • Never having had children.
  • Ashkenazi (eastern European) Jewish ancestry.

Other potential risk factors include:

  • Having previously had hormone replacement therapy.
  • Chronic inflammation of fallopian tubes (salpingitis).

Not everyone with these risk factors will develop the disease, and some people who have the disease may have none of these risk factors. See your general practitioner (GP) if you are concerned.

Symptoms

Fallopian tube cancer may appear asymptomatic in the early stages of disease. As the tumour progresses, some of the following symptoms may appear:

  • An abdominal and/or pelvic mass.
  • Pain, swelling and/or pressure in the abdomen, pelvis, lower legs and/or back.
  • A feeling of abdominal fullness and/or heaviness.
  • Changes in bathroom habits, potentially including:
    • Constipation.
    • Feeling of incomplete urination.
    • Polyuria.
    • Urgent urination.
  • Changes in digestion, potentially including:
    • Feeling full quickly.
    • Heartburn.
    • Gas.
    • Indigestion.
    • Nausea and/or vomiting.
  • Unexplainable weight loss/loss of appetite.
  • Fatigue.
  • Abnormal vaginal bleeding and/or discharge between periods or after menopause.
  • Painful intercourse.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have fallopian tube cancer, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
  • Pelvic examination.
  • Imaging tests, potentially including:
    • Pelvic ultrasound.
    • Transvaginal ultrasound.
  • Blood tests.
  • Diagnostic laparoscopy.
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.